The technology arm of Ping An Insurance Group has completed clinical trials for its retinal disease screening system. The intelligent optical coherence tomography (OCT) system is believed to be the first to integrate AI detection in an OCT retinal imaging device, and was jointly developed with Optovue-based US.
The technology arm of Ping An Insurance Group has completed clinical trials for its retinal disease screening system. The intelligent optical coherence tomography (OCT) system is believed to be the first to integrate AI detection in an OCT retinal imaging device, and was jointly developed with US-based Optovue.